Nora Draper · Parliamentary Secretary Assistant, Health Canada (HC)
Advocate for the role of health information professionals in discussion relating to the adoption of Artificial Intelligence in the health sector.Read more
Advocate on issues relating to the role of Health Information Professionals as it relates to the future of the workforce.
Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
Discussions with federal officials to seek funding support for the growth and international expansion of Canada's cell and gene therapy and regenerative medicine sector, including potential federal investment to scale domestic biomanufacturing capacity, strengthen supply chain resilience for critical medicines, and support Canada's continued leadership in advanced therapies research, development, and commercialization.Read more
Greg Reade · Assistant Secretary to the Cabinet, Economic Regional Development Policy, Privy Council Office (PCO)
Discussions with federal officials to seek funding support for the growth and international expansion of Canada's cell and gene therapy and regenerative medicine sector, including potential federal investment to scale domestic biomanufacturing capacity, strengthen supply chain resilience for critical medicines, and support Canada's continued leadership in advanced therapies research, development, and commercialization.Read more
Discussions with federal officials to seek funding support for the growth and international expansion of Canada's cell and gene therapy and regenerative medicine sector, including potential federal investment to scale domestic biomanufacturing capacity, strengthen supply chain resilience for critical medicines, and support Canada's continued leadership in advanced therapies research, development, and commercialization.Read more
Jessica Fullerton · Director of Policy, Global Affairs Canada (GAC)
Discussions with federal officials to seek funding support for the growth and international expansion of Canada's cell and gene therapy and regenerative medicine sector, including potential federal investment to scale domestic biomanufacturing capacity, strengthen supply chain resilience for critical medicines, and support Canada's continued leadership in advanced therapies research, development, and commercialization.Read more
Nicholas Chesterley · Director General, Finance Canada (FIN)
Discussions with federal officials to seek funding support for the growth and international expansion of Canada's cell and gene therapy and regenerative medicine sector, including potential federal investment to scale domestic biomanufacturing capacity, strengthen supply chain resilience for critical medicines, and support Canada's continued leadership in advanced therapies research, development, and commercialization.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.